Diabetes
-
Engelhardt lands stem cell transplant research grant
Up to 60 percent of patients who receive a stem cell transplant using cells from another donor will develop post-transplant diabetes mellitus, which can increase the rate of complications and death after the procedure. Read MoreSep 11, 2014
-
VU study shows common diabetes drug can slow chronic kidney disease progression
Vanderbilt investigators have demonstrated in two studies that metformin-based treatments delay the onset and progression of chronic kidney disease (CKD) compared with other treatments for diabetes. Read MoreJun 26, 2014
-
Health Plus offers new diabetes prevention program
(iStock) Health Plus is offering an exciting new program, the National Diabetes Prevention Program, proven to prevent or delay type 2 diabetes through group sessions with a trained lifestyle coach. It is for faculty and staff who have pre-diabetes or are high risk for diabetes. The… Read MoreJun 12, 2014
-
University-Wide Limited Submission Opportunity: American Diabetes Association
Vanderbilt may nominate one Medical Center and one University candidate for the 2014 Pathway to Stop Diabetes awards competition. Read MoreMay 22, 2014
-
CaMKII enhances insulin secretion
The protein CaMKII acts as a calcium sensor in a positive feedback pathway that enhances glucose-stimulated insulin secretion. Read MoreMay 14, 2014
-
Matrix remodeling and insulin resistance
The extracellular matrix that surrounds cells plays a role in the development of insulin resistance. Read MoreApr 10, 2014
-
Diabetes study offers medication adherence options
Knowing when to take a medication — and what to do if a dose is missed — could greatly improve adherence to diabetes medications and glycemic control among adults with type 2 diabetes, according to a Vanderbilt study published in the journal Diabetes Care. Read MoreMar 20, 2014
-
Diabetes researchers track cells’ ability to regenerate
Vanderbilt University scientists have found evidence that the insulin-secreting beta cells of the pancreas, which are either killed or become dysfunctional in the two main forms of diabetes, have the capacity to regenerate. Read MoreMar 13, 2014
-
African American women and pre-diabetic outcomes topic of meeting March 7
The Meharry-Vanderbilt Community Engaged Research Core is hosting its monthly Community Research Partners meeting Friday, March 7. Join us for a light breakfast and coffee to hear about findings from a recently completed clinical trial involving pre-diabetic African American women. Presenters will share new findings about group biology as… Read MoreFeb 25, 2014
-
Pilot and feasibility grants available for research related to diabetes and obesity
The Vanderbilt Diabetes Center, the Vanderbilt Diabetes Research and Training Center (DRTC) and the Vanderbilt Center for Diabetes Translation Research (CDTR) announce the availability of pilot and feasibility grants in the following areas: Translational or behavioral science research (Type II translational research) related to… Read MoreJan 28, 2014
-
Searching for beta cell stimulators
Vanderbilt researchers describe a new technique for identifying factors that stimulate the proliferation of pancreatic beta cells – factors that might offer therapeutic options for diabetes. Read MoreJan 13, 2014
-
Top 10 research stories of 2013
This year’s most popular research stories plumbed mysteries of the brain, examined complex social phenomena, shed light on dark matter, uncovered a surprising link between our three greatest health threats and more. Read MoreDec 23, 2013
-
Glucose control study gives patients new path to health
The IDIOM study is designed to compare how a diet with moderate caloric restriction, alone or with long-acting insulin, affects areas of the brain’s dopamine system that are involved in food intake, reward and the sense of pleasure people get from eating. Read MoreOct 24, 2013
-
Relaxin combats insulin resistance
The hormone relaxin may offer a novel approach for treating diet-induced insulin resistance. Read MoreOct 16, 2013
-
Students receive national award to help commercialize wound-healing foam
A pair of Vanderbilt graduate students has received a national award of $15,000 to pursue the development of an unique synthetic foam as a new treatment for deep skin wounds such as chronic foot ulcers caused by diabetes. Read MoreOct 2, 2013
-
Researchers identify novel biomarker for diabetes risk
Researchers at the Vanderbilt Heart and Vascular Institute and Massachusetts General Hospital have identified a biomarker that can predict diabetes risk up to 10 years before onset of the disease. Read MoreSep 17, 2013
-
VU tracking drug’s ability to prevent type 1 diabetes
Vanderbilt’s Eskind Diabetes Clinic has been selected to examine the ability of the drug abatacept to prevent type 1 diabetes (T1D). As part of the TrialNet consortium, Vanderbilt will be one of 14 North American sites observing the effects of the drug in people at high risk to develop T1D. Read MoreSep 12, 2013
-
‘Yo-yo dieting’ inflames fat tissue
Gaining and losing weight during “yo-yo dieting” may contribute to an exaggerated immune response in fat tissue that increases metabolic dysfunction more than steady weight gain alone. Read MoreAug 9, 2013
-
Photo: Researching diabetes
Last week, 130 students from more than 75 medical schools across the nation were at Vanderbilt to take part in the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) Medical Student Research Symposium, sponsored by the National Institutes of Health and organized by the Vanderbilt Diabetes Center. Read MoreAug 8, 2013
-
New service helps patients keep glucose levels on track
Following her successful heart valve surgery at Vanderbilt, Gwendolyn English and her family faced a long journey home to Florida. Her family was concerned about the trip, because English has diabetes and her blood sugar levels had been fluctuating erratically. Read MoreJul 11, 2013